Dr. Ira Jacobson

Dr. Ira JacobsonDr. Jacobson is a Fellow of the American College of Physicians, American College of Gastroenterology, and American Gastroenterological Association, and a member of the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. In addition to maintaining an active practice with a focus on patients with liver disease, he has been an investigator in many trials on antiviral therapy for hepatitis B and C, including the pivotal trials on interferon-based therapy, since the 1980s. He has been lead principal investigator and author of a number of trials, including WIN-R trial (weight based ribavirin with peginterferon), ADVANCE (telaprevir), QUEST-1 (simeprevir), POSITRON (sofosbuvir), and STARTVerso3 (faldaprevir). He has served on the Gastroenterology and Transplant Hepatology Boards of the American Board of Internal Medicine, as Associate Editor of the Journal of Hepatology, and as a reviewer for several other journals. He has authored or co-authored over 200 peer-reviewed papers, chapters and reviews, including papers in the New England Journal of Medicine, Gastroenterology, Hepatology, Journal of Hepatology, Journal of Viral Hepatitis, Clinical Gastroenterology and Hepatology, and others. He has edited two books on ERCP and a volume on hepatitis B for Clinics in Liver Disease.

He has co-chaired the annual Viral Hepatitis Congress in Frankfurt, Germany since 2012. Dr. Jacobson was recently named Co-Chief Medical Editor of HCV Next, a new publication from Slack Incorporated that also appears on Healio.com/HCV. Board Certifications American Board of Internal Medicine: 11/19/1985 American Board of Gastroenterology: 09/15/1982 Transplant Hepatology: 11/17/06 - 12/31/2016

For more information visit www.mountsinai.org/profiles/ira-jacobson

Gastroenterology Website Design | Medical Website Design by Vital Element, Inc.